Overview Fundamentals API Earnings EOD API Sample Code Pricing

Enanta Pharmaceuticals Inc (9EP F) stock market data APIs

€10.4 0.1(1%) as of October 31, 2024
Price chart is built with Anychart

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Enanta Pharmaceuticals Inc Financial Data Overview

10.3
10.4
-
10.4
10.1
7.5-16.1
221 M
21 189 K
71 960 K
-1.19
0.584
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '9EP',
Type: 'Common Stock',
Name: 'Enanta Pharmaceuticals Inc',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

Enanta Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 71 960 K
  • EBITDA -120 341 000
  • Earnings Per Share -5.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Enanta Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2021-08-05
  • EPS/Forecast -1.28

Get Enanta Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com